Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 6
2018 25
2019 56
2020 74
2021 95
2022 86
2023 87
2024 84

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Chemotherapy: a double-edged sword in cancer treatment.
Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, Falak R. Behranvand N, et al. Cancer Immunol Immunother. 2022 Mar;71(3):507-526. doi: 10.1007/s00262-021-03013-3. Epub 2021 Aug 5. Cancer Immunol Immunother. 2022. PMID: 34355266 Free PMC article. Review.
Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial.
Attaran F, Emami S, Sohrabi M, Malek M, Ajdarkosh H, Khoonsari M, Ismail-Beigi F, Khamseh ME. Attaran F, et al. BMC Gastroenterol. 2023 Sep 23;23(1):327. doi: 10.1186/s12876-023-02948-4. BMC Gastroenterol. 2023. PMID: 37742004 Free PMC article. Clinical Trial.
Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials.
Eissazade N, Mosavari H, Eghdami S, Boroon M, Ashrafi F, Shalbafan M. Eissazade N, et al. Sci Rep. 2023 Nov 27;13(1):20837. doi: 10.1038/s41598-023-47931-x. Sci Rep. 2023. PMID: 38012263 Free PMC article.
437 results